OREANDA-NEWS. December 7, 2011. Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading IT services, consulting and business solutions organisation, announced, today, that it has been designated as a leader in the life science R&D IT outsourcing market by the prominent global market intelligence firm IDC Health Insights in its report, IDC MarketScape: Worldwide Life Science R&D IT Outsourcing 2011 Vendor Assessment. Among the attributes that garnered TCS the honour are the company’s more than twenty-year history of experience in the life science field, its broad portfolio of industry-specific services and TCS’s ability to effectively meet increasing customer demands for resources across the entire life science value chain.

IDC Marketscape reports are designed to identify factors for effectiveness and success in particular markets, both long-term and short-term, and then evaluate vendors in the market against those factors. The key criteria for defining excellence in the study focused on a number of factors including project experience in the life sciences R&D outsourcing market, strength of project leaders and their teams, breadth of service offerings and quality of work and customer satisfaction.

"Providing services to life science companies of all types and sizes, TCS has a well-balanced portfolio of IT and BPO service offerings," said research director, Dr Alan Louie, IDC Health Insights. "TCS is among the most experienced vendors in the R&D IT outsourcing space, with strong experience in all of the services the company provides, significant industry-specific knowledge, competitive pricing, and the ability to easily meet increasing customer demand for resources. "With its significant expertise, accumulating life science IP assets, and strong investment in growth, TCS should continue to be a dominant player in the life science R&D space for years to come."

TCS has collaborated with the world’s leading life science and healthcare organisations for over two decades in diverse geographies and has leveraged this experience to enable customers to address current challenges and meet future business requirements with efficient, cost-effective solutions.

“We are honoured to receive the designation of leader in the life science R&D outsourcing IT market from IDC Health Insights — an organisation that itself is recognised as a true leader and premier global market intelligence firm,” said Debashis Ghosh, president, TCS's life sciences, manufacturing, energy and resources business group. “As the life science market continues to evolve at an increasingly rapid pace, TCS will remain ahead of the curve and committed to providing our customers with the capabilities and support they have come to expect from us to remain successful.”